COMMUNIQUÉS West-GlobeNewswire

AB Science situation and future prospects presented during the Combined General Shareholders' Meeting held on July 29 2018
03/07/2018
Paris, July 3, 2018, 6.30pm Results of the June 29, 2018 Combined General Shareholders' Meeting A Combined General Shareholders' Meeting was held on July 29, 2018 in Paris. The shareholders present or represented [...]
AB Science : Situation et les perspectives de l'entreprise présentées lors de l'Assemblée Générale Mixte du 29 juillet 2018
03/07/2018
Paris, 3 juillet 2018, 18h30 Résultats de l'Assemblée Générale Mixte du 29 juin 2018 Les actionnaires de la société AB Science se sont réunis en Assemblée Générale Mixte, le vendredi 29 juillet 2018 à Paris. Les [...]
Capital Increase in Genmab as a Result of Employee Warrant Exercise
03/07/2018
Company Announcement Copenhagen, Denmark; July 3, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 24,025 shares as a consequence of the exercise of employee warrants. The increase is [...]
EUROBIO SCIENTIFIC : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ CONCLU AVEC LA SOCIÉTÉ DE BOURSE GILBERT DUPONT
03/07/2018
BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ D'EUROBIO SCIENTIFIC CONCLU AVEC LA SOCIÉTÉ DE BOURSE GILBERT DUPONT Paris, le 3 juillet 2018 - 17h45 Au titre du contrat de liquidité confié à la Société de Bourse Gilbert [...]
Agility Health Reports First Quarter 2018 Financial Results
03/07/2018
HAMILTON, Ontario, July 03, 2018 (GLOBE NEWSWIRE) -- Agility Health, Inc. (TSXV:AHI) (“ Agility Health ” or “ Corporation ”), a leading provider of orthotics, prosthetics and foot care services in Canada, today reported [...]
Sorrento Acquires the Sofusa™ Lymphatic Delivery Platform for Immune-Oncology (I-O) Antibody Therapeutics
03/07/2018
SAN DIEGO, July 03, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ:SRNE) ("Sorrento") announced today that it acquired the Sofusa™ lymphatic delivery technology platform from Kimberly-Clark Corporation for [...]
Planet 13: Newly Public, Set to Make Cannabis a Vegas Feature Attraction -- CFN Media
03/07/2018
SEATTLE, July 03, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering [...]
Pascal Biosciences: Cannabinoids Could Play a Role in Destroying Cancer Cells -- CFN Media
03/07/2018
SEATTLE, July 03, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an article [...]
Grown Rogue: A Leading Seed-to-Experience Cannabis Brand -- CFN Media
03/07/2018
Seattle, Washington, July 03, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an [...]
Exclusive CFN Media Interview: RISE Life Science Study on Cannabis and Sexual Health (Part 1)
03/07/2018
SEATTLE, July 03, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an exclusive interview [...]
Novelion Therapeutics Appoints Mark Corrigan, M.D. as Executive Chair of the Board of Directors
03/07/2018
Chief Operating Officer Jeff Hackman Appointed as Interim Chief Executive Officer (CEO) VANCOUVER, British Columbia, July 03, 2018 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN) today announced that Mark [...]
Maple Leaf Green World Inc. Announces Voting Results from Annual General Meeting Regarding Nominated Directors
03/07/2018
CALGARY, Alberta, July 03, 2018 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“ Maple Leaf ” or the “ Company ”) (NEO:MGW) (OTCQB:MGWFF) announces the voting results from its annual general meeting of shareholders [...]
Hemispherx Notes the Importance of Immunizations During Upcoming National Immunization Awareness Month and Potential of Ampligen in Influenza Vaccine Strategies
03/07/2018
ORLANDO, Fla., July 03, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB), an immuno-pharma R&D company focused on unmet medical needs in immunology, is pleased to enthusiastically support [...]
Portola Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
03/07/2018
SOUTH SAN FRANCISCO, Calif., July 03, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (NASDAQ:PTLA) announced today that on June 27, 2018, the Compensation Committee of the Board of Directors approved, [...]
Globus Medical Adds Two Innovative Solutions to Growing Trauma Portfolio
03/07/2018
Introducing ANTHEM® Ankle Fracture and Proximal Humerus Plate Systems AUDUBON, Pa., July 03, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, announced today the [...]
Viveve Submits VIVEVE II Clinical Study 30-Day Patient Safety Data to FDA
03/07/2018
No serious adverse events reported in the submission Final study results could support a marketing application for expanded U.S. indication for the improvement of sexual function in women ENGLEWOOD, Colo., July 03, 2018 [...]
Zecotek Opens LFS Crystal Production Facility in Shanghai, China
03/07/2018
VANCOUVER, British Columbia, July 03, 2018 (GLOBE NEWSWIRE) -- Zecotek Photonics Inc. (“ Zecotek ” or the “ Company ”) (TSX-V:ZMS) (Frankfurt:W1I) (OTCPK:ZMSPF), a developer of leading-edge photonics technologies for [...]
Auris Medical Announces Publication Confirming Dose-Dependent Effects of Betahistine and Relationship to Bioavailability in Cat Model of Acute Vertigo
03/07/2018
Zug, Switzerland, July 3, 2018 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and mental health [...]
Elite Pharmaceuticals Receives FDA Approval for Generic Percocet® Tablets
03/07/2018
NORTHVALE, N.J., July 03, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, [...]

Pages